Trump reiterates plan to impose tariffs on pharmaceuticals
Seeking Alpha — March 24, 2025
"Interestingly, most brand-name drugs sold in the U.S. have their APIs and finishing done in the U.S. or a country with stringent manufacturing regulations. A 2022 evaluation of the top 100 Medicare Part D drugs based on spend from PharmacyChecker Research found that 32 were finished in the U.S. and another 67 were finished in countries that have strong pharma manufacturing protocols such as European Union countries, Canada, Japan, Singapore, Switzerland, and the United Kingdom."